Evidence map›Paper›PMID 35907040›Full record

ArticleArchives of microbiology2022

Degradability of commercial mixtures of polychlorobiphenyls by three Rhodococcus strains.

Tatyana I Gorbunova, Darya O Egorova, Marina G Pervova, Tatyana D Kir'yanova, Elena G Plotnikova

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. (Pan)genomic analysis of twoMicrobiology spectrum · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tatyana I GorbunovaI.Ya. Postovskii Institute of Organic Synthesis, Yekaterinburg, 620137, Russia. gorbunova@ios.uran.ru.ORCID http://orcid.org/0000-0003-4288-1988
Darya O EgorovaInstitute of Ecology and Genetics of Microorganisms, Perm, 614081, Russia.
Marina G PervovaI.Ya. Postovskii Institute of Organic Synthesis, Yekaterinburg, 620137, Russia.
Tatyana D Kir'yanovaInstitute of Ecology and Genetics of Microorganisms, Perm, 614081, Russia.
Elena G PlotnikovaInstitute of Ecology and Genetics of Microorganisms, Perm, 614081, Russia.
Institute of Ecology and Genetics of Microorganisms · RUInstitute of Organic Synthesis · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biodegradative characteristics were investigated for the commercially available mixtures of polychlorinated biphenyls (PCBs) Trikhlorbifenil and Sovol degraded by the Rhodococcus wratislaviensis КT112-7, Rhodococcus wratislaviensis CH628 and Rhodococcus ruber P25 strains isolated from the natural habitats. For bioutilization of the Trikhlorbifenil, all three strains were found to have a high biodegrading potential: the complete destruction was achieved in 10-14 days. For the mixture Sovol, the bioutilization parameters were found to be of lower values: the degradation of the PCBs congeners was 96-98% after 14 days. For the tested polychlorobiphenyl mixtures, the structural specificities of congeners are discussed, the genes encoding monooxygenases are revealed, and explanation is given to the differences in biodegradative characteristics of the Rhodococcus strains towards di-, tri-, tetra-, penta-, hexa- and heptachlorobiphenyls. The presented data are highly relevant for environmental remediation of objects polluted with the extremely hazardous polychlorobiphenyls.

Indexed as

Polychlorinated BiphenylsRhodococcusBiodegradation, EnvironmentalPolychlorinated BiphenylsBiodegradabilityCongenersPolychlorobiphenylsRhodococcus strains

Identifiers

PMID35907040
OpenAlexW4288684639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.